Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
Clinical trial NCT02294058 · COMPLETED
Trial details
- NCT number
- NCT02294058
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-03
- Primary completion
- 2016-12-22
- Enrollment
- 1346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.